Buprenorphine is on the market like a monoproduct or in a put together formulation with naloxone, an opioid antagonist, used to reduce diversion due to the fact buprenorphine combined with naloxone causes significant withdrawal symptoms when injected. Nonetheless, naloxone is not orally Lively, so withdrawal symptoms tend not to manifest when used